Âé¶¹´«Ã½

Health

Anti-doping agency warns athletes of black market drug

26 March 2013

DRUG cheats watch out. The World Anti-Doping Agency (WADA) has taken the rare step of after discovering abuse of a black market drug that causes multiple cancers in rodents.

The drug, called GW501516, was originally developed by pharmaceutical company GlaxoSmithKline (GSK) to stimulate muscles to , in order to raise levels of “good” cholesterol. But the company abandoned further development in 2006 after tests on rats showed that at all doses, the drug rapidly causes cancers in a multitude of organs, including the liver, bladder, stomach, skin, thyroid, tongue, testes, ovaries and womb. “GSK does not manufacture it or authorise its sale,” says a company spokesman.

In 2009, , and the agency added the drug to its list of prohibited substances that year.

The drug is openly promoted on websites for bodybuilders and athletes.

Topics:

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with Âé¶¹´«Ã½ events and special offers.

Sign up
Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop